Juncture Wealth Strategies, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Juncture Wealth Strategies, LLC
- $232 Million
- Q1 2024
A detailed history of Juncture Wealth Strategies, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Juncture Wealth Strategies, LLC holds 94,583 shares of CPRX stock, worth $1.44 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
94,583
Previous 10,947
764.01%
Holding current value
$1.44 Million
Previous $184,000
719.02%
% of portfolio
0.65%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding CPRX
# of Institutions
277Shares Held
95.7MCall Options Held
40.6KPut Options Held
67.2K-
Black Rock Inc. New York, NY17.7MShares$269 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY9.13MShares$139 Million3.01% of portfolio
-
State Street Corp Boston, MA8.15MShares$124 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.98MShares$121 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.74MShares$41.6 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $1.56B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...